HeartBeam (BEAT) Stock Analysis
NASDAQHealthcareMedical - Specialties
What HeartBeam does
HeartBeam, Inc. is a development stage company, which engages in cardiovascular diagnostic technology. Its electrocardiogram (ECG) collection device provides physicians with cardiac diagnostic information for a patient that is outside of a medical institution. The device sends ECG signals to the patient's smartphone and on to a cloud-based software expert system. The company was founded by Branislav Vajdic in 2015 and is headquartered in Santa Clara, CA.
Key metrics
ETFs linked to BEAT
Broad-market and Healthcare sector ETFs an investor holding HeartBeam is often also exposed to. Open an ETF page to see its actual top holdings.
PortView Portfolio Insights
PortView analyzes how BEAT fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze BEAT in PortView →Similar companies
Frequently asked questions
- What is the ticker symbol for HeartBeam?
- HeartBeam trades under the ticker BEAT on NASDAQ.
- Which exchange is BEAT listed on?
- BEAT is listed on NASDAQ.
- What sector does HeartBeam operate in?
- HeartBeam is classified in the Healthcare sector (Medical - Specialties industry).
- How can PortView help analyze BEAT in a portfolio?
- PortView shows BEAT's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.